Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory subm...
Preparing for ICH GCP E6(R3) implementation
A guide to assessing the impact, risk and requirements of the change
Read the whitepaperMeeting requirements for Joint Clinical Assessments
A planning guide for health technology developers
Read the whitepaper
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
ICON Cares program
Expresses our passion and achievements around environmental, social and governance (ESG) efforts.
Webinars
How Functional Service Provision supports sponsors in Korea
28 October 2025. Register now.
Beyond the bench: The advantages of GMP over USP compounding in early phase development
6 November 2025. Register now.
Strategic approaches for early clinical trials in neurodegenerative diseases
18 November 2025. Register now.
